SLF
ALXN

Sun Life Financial’s Alexion Pharmaceuticals ALXN Stock Holding History

Sun Life Financial’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-131
Closed -$20K – 515
2021
Q1 		$20K Buy
131
+1
+0.8% +$155 ﹤0.01% 273
2020
Q4 		$20K Sell
130
-4
-3% -$514 ﹤0.01% 259
2020
Q3 		$15K Buy
+134
New +$14.5K ﹤0.01% 289
2017
Q2 		– Sell
-15
Closed -$121 – 590
2017
Q1 		$121 Buy
+15
New +$1.93K ﹤0.01% 366

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Sun Life Financial's ALXN Position: Q2 2021 in Review

Sun Life Financial sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 131 shares — an estimated $20K sold.

Sun Life Financial first reported a position in ALXN in Q1 2017 and held it in 4 quarters. The position peaked at $20K in Q1 2021. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Sun Life Financial reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sun Life Financial sold 131 Alexion Pharmaceuticals shares in Q2 2021, an estimated $20K.
  • Sun Life Financial first reported a position in Alexion Pharmaceuticals in Q1 2017 and held it in 4 quarters.
  • Sun Life Financial's Alexion Pharmaceuticals position peaked at $20K in Q1 2021.
  • 710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Sun Life Financial's 13F filing for Q2 2021, filed 10 Aug 2021.